nutritional support and functional capacity in copd
TRANSCRIPT
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
1/14
REVIEW
Nutritional support and functional capacity in chronic obstructive
pulmonary disease: A systematic review and meta-analysis
PETER F. COLLINS,1,2 MARINOS ELIA1 AND REBECCA J. STRATTON1
1Faculty of Medicine, Institute of Human Nutrition, Southampton General Hospital, University of Southampton,
Southampton, UK, and 2Faculty of Health, School of Exercise and Nutrition Sciences, Queensland University of Technology,
Brisbane, Australia
ABSTRACT
Currently, there is confusion about the value of usingnutritional support to treat malnutrition and improve
functional outcomes in chronic obstructive pulmonarydisease (COPD). This systematic review and meta-analysis of randomized, controlled trials (RCT) aimedto clarify the effectiveness of nutritional support inimproving functional outcomes in COPD. A systematicreview identified 12 RCT (n= 448) in stable COPDpatients investigating the effects of nutritional support(dietary advice (1 RCT), oral nutritional supplements(10 RCT), enteral tube feeding (1 RCT)) versus controlon functional outcomes. Meta-analysis of the changesinduced by intervention found that while respiratoryfunction (forced expiratory volume in 1 s, lung capac-ity, blood gases) was unresponsive to nutritionalsupport, both inspiratory and expiratory musclestrength (maximal inspiratory mouth pressure +3.86
standard error (SE) 1.89 cm H2O, P=0.041; maximalexpiratory mouth pressure +11.85 SE 5.54 cm H2O,P= 0.032) and handgrip strength (+1.35 SE 0.69 kg,P=0.05) were significantly improved and associatedwith weight gains of2 kg. Nutritional support pro-duced significant improvements in quality of life insome trials,although meta-analysis was not possible. Italso led to improved exercise performance andenhancement of exercise rehabilitation programmes.This systematic review and meta-analysis demon-strates that nutritional support in COPD results in sig-nificant improvements in a number of clinicallyrelevant functional outcomes, complementing a previ-ous review showing improvements in nutritionalintake and weight.
Key words: chronic obstructive pulmonary disease, functionalcapacity, meta-analysis, nutritional support.
Abbreviations: BMI, body mass index; COPD, chronicobstructive pulmonary disease; ETF, enteral tube feeding; FEV1,
forced expiratory volume in 1 s; HGS, handgrip strength; IBW,
ideal body weight; ONS, oral nutritional supplements; PE max,
maximal expiratory mouth pressure; PI max, maximal inspiratorymouth pressure; QoL, quality of life; RCT, randomized, controlled
trial; SD, standard deviation; SE, standard error.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is aprogressive multi-organ systemic disease and a majorcause of morbidity and disability in aging. WhileCOPD has its primary effects in the lungs, adversestructural and functional changes also occur in thetissues of the heart and skeletal muscle, leading toindividuals with COPD experiencing a range of dis-
abilities that impact on their well-being and ability toperform daily activities. Reduced respiratory functionand a decline in fat-free mass result in reduced exer-cise tolerance1 and peripheral muscle weakness,2,3
both disabling features of COPD, which are associatedwith a poorer quality of life (QoL). Fat-free massdepletion (even if body mass index (BMI) is within theideal range)4,5 has recently been found to be a signifi-cant independent predictor of disability even afteradjustment for disease severity.6
Disease-related malnutrition is a common problemin individuals with COPD, with between 30% and 60%of inpatients and 10% and 45% of outpatients said tobe at risk.7 Malnourished COPD patients demonstrategreater gas trapping, lower diffusing capacity and areduced exercise performance when compared withheavier non-malnourished patients with a similarseverity of disease.8 However, the exact causal linksbetween malnutrition and COPD are difficult toestablish. Malnutrition may be the consequence ofgreater disease severity. Alternatively, malnutritionmay be responsible for the wasting of the musclesinvolved in breathing, exacerbating the progressivenature of COPD. Similarly, in chronic anorexianervosa, the loss of body weight includes substantialloss of lung tissue, which develops emphysematous-like changes.9 In addition to the uncertainty about thecausal links between malnutrition and COPD, there
Correspondence: Marinos Elia, Institute of Human Nutrition,
Faculty of Medicine, University of Southampton, MP 113, South-
ampton General Hospital, Southampton SO16 6YD, UK. Email:
Conflict of Interest Statement: Rebecca Stratton, PhD, RD,
RNutr, is also an employee of Nutricia Ltd.
Received 15 November 2012; invited to revise 9 January 2013;
revised 4 February 2013; accepted 7 February 2013 (Associate
Editor: Paul Thomas).
bs_bs_banner
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629doi: 10.1111/resp.12070
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
2/14
are controversies about how effective nutritionalsupport is in this patient group. Previous reviews andmeta-analyses1012 suggested that malnutrition fails torespond to nutritional treatment in COPD finding nosignificant improvements in anthropometric or func-tional measures. These conclusions have beenchallenged by several randomized, controlled trials(RCT),1316 and a recently published meta-analysis
concluded that nutritional support wasable to signifi-cantly increase nutritional intake (energy andprotein), which was associated with a significantimprovement in a variety of anthropometric meas-ures.17 The contrast in conclusions between thereviews has been largely attributed to methodologicaldifferences in data analysis discussed at length in thepaper.17 In essence, the previous Cochrane Collabora-tion review12 carried out cross-sectional analysisbetween intervention and control groups but failed toaccount for baseline variability. The other reviewaccounted for pre- and post-intervention variabilityfinding a number of significant within-group im-provements to be masked by cross-sectional analy-
sis.17
Nevertheless, confusion remains over whetherthe recent positive findings translate beyond nutri-tional intake and body weight, and into functionalimprovements. The aim of this current systematicreview is to establish whether nutritional supportresults in significant improvements in functionalcapacity and QoL in patients with COPD.
METHODS
Search strategy and identification of trialsThe review was planned, conducted and reportedaccording to published guidelines.1820 The same
methodological approach to that of the previousreview17 was used; however, an updated systematicsearch of the literature was carried out in July 2012(databases accessed up to 4 July 2012) in order toidentify any additional RCT investigating nutritionalsupport in COPD reporting functional outcomes(Fig. 1). Potentially relevant studies were identifiedby searching electronic databases. The databasessearched included PubMed (accessed 4 July 2012),
Web of Science (accessed 4 July 2012) and OVID(accessed 4 July 2012). In order to identify the largestnumber of trials, a broad search strategy was imple-mented, although trials were restricted to English lan-guage citations only. The search terms and meshheadings used included: chronic obstructive pulmo-nary disease, COPD, emphysema, weight, depletion,diet*, nutrition*, supplement*, protein, carbohydrate,
calori*, feed*, malnutrit*, nourish*, sip, nutritionintervention, nutrition support. These search termswere also systematically combined in order to identifytrials. In addition to electronic database searching,manual searching of previous reviews on nutritionalsupport in COPD as well as references of identifiedtrials was undertaken.
Studies were initially screened by reading theabstract, and where a study could not be excluded,the full article was reviewed. The assessment of trialeligibility was done by two independent assessors(P.F.C. and M.E.), with any disagreement discussedprior to inclusion.
Inclusion and exclusion criteriaStudies were deemed eligible for inclusion in thereview if they conformed to the pre-determinedinclusion criteria. To investigate the overall efficacy ofnutritional support (food strategies (food fortifica-tion, food snacks, dietary advice), oral nutritionalsupplements (ONS) and enteral tube feeding (ETF),the following inclusion criteria for trials were devised:(i) randomized trials; (ii) intervention with food strat-egies, ONS or ETF; (iii) duration of intervention >2weeks; (iv) control group receiving placebo or nodietary intervention (e.g. usual care, which couldinclude advice and encouragement to eat), but other-wise the same treatment as the intervention group; (v)
stable patients with a diagnosis of COPD (not exacer-bating); (vi) human studies only; and (vii) English lan-guage only.
The intervention could provide either a proportionor all of the daily nutritional requirements for energy,protein and micronutrients, and where feeds wereused (e.g. ONS), these could be nutritionally completeor incomplete. Studies using parenteral nutrition andsingle nutrient interventions were excluded.
Figure 1 Study selection process.
Nutrition support in COPD 617
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
3/14
Data extractionFunctional outcome data sought included respiratoryfunction (forced expiratory volume in 1 s (FEV1)), res-piratory muscle strength (maximal inspiratory mouthpressure (PI max) and maximal expiratory mouthpressure (PE max)), peripheral muscle strength(maximum voluntary handgrip strength (HGS)), exer-cise performance (walking distance), QoL and addi-
tional outcomes including immunological measures.In trials where mean values were reported withoutstandard deviations (SD) or standard errors (SE), theywere calculated from reportedP-values. In one trialthat assessed HGS,15 data reported in kilograms wereconsidered to be unrealistic and therefore assumed tobe in pounds. Whenever possible, data from indi-vidual subjects were used to calculate the summaryvalues from specific studies.15,21 Graphical data werealso used to establish summary values either whenthere were no other data reported or when reportedresults were imprecise due to rounding.22
Quality assessmentThe quality of included studies was assessed by oneresearcher (P.F.C.) and independently verified byanother assessor (R.J.S.) using the most commonlyused scoring system (Jadad scoring system).23 TheJadad scoring system comprises of three componentsaddressing whether a study is described as rand-omized, whether it is double-blind and whether drop-outs were accounted for. It then scores on theappropriateness of the randomization and blinding.The Jadad scoring system does not assess the samplesize of trials.
Synthesis of data and statistical analysis
Following the extraction of data from included trials,where appropriate and feasible, the results of compa-rable outcome measures were combined in order tocarry out random effects meta-analyses using Com-prehensive Meta-analysis (Biostat, Inc., Englewood,
NJ, USA, version 2) (Table 1). The overall treatmentdifference was considered statistically significant ifthe P-value was
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
4/14
Table
2
Summaryoftherandom
ized,controlledtrialsincludedinthe
systematicreviewaccordingtointervention
Study
Samplesize
(treatment/
control)
C
haracteristics/setting
(interventionvs
control)
Nu
tritionalintervention
(type/prescribed
amount/duration)
Co
ntrolgroup
Outcomemeasur
es
Studyquality
(Jadadscore)
ONSDeLetter66
(thesis)
18/17
Maln
ourished
82.8%
IBW
Outp
atients
ONS(Pulm
ocare,1.5kcal/mL)1can/day
ONStarget:+355kcal/dayand15g
protein/
day
9weeks
Usualdiet
FEV1,6MWT
11000(2)
Efthimiou
etal.13
7/7
Maln
ourished
79.5%
versus81.3%IBW
Outp
atients
59.9versus64.1years
ONS(Buil
dUp,1.13kcal/mL)
ONStarget:+6401280kcal/daysand
3672g
protein/day,encouragement
toeatp
rovidedtobothgroups
12weeks
Usualdiet(with
enco
uragement)
FEV1,PImax,PEma
x,
sternomastoid
strength,HGS,6M
WT,
breathlessnessscale,
generalwell-being
10000(1)
Knowles
etal.48
13/12
Nour
ishedandmalnourished
61108%IBW
Outp
atients
68ve
rsus70years
ONS(Sustacal,1kcal/mL,0.043g
protein/
kcal)
ONStarget:ToincreasetotalEIby50%
Weeklyen
couragement:8weeks
Usualdiet
FEV1,PImax,PEma
x,
lymphocytecount,
serumtransferring
11000(2)
Lewis
etal.50
10/11
Maln
ourished
86.3%
versus84.6%IBW
Outp
atients
65.1versus59.3years
ONS(Isoc
alHCN,2kcal/mL)
ONStarget:5001000kcal/dayand
1938g
protein/day,encouragement
8weeks
Usualdiet
FEV1,PImax,PEma
x,
HGS
10000(1)
Otte
etal.52
13/15
Maln
ourished
77%
versus73%IBW
Outp
atients
56.5years
ONS(Nov
o,1kcal/mL)
ONStarget:+400kcal/dayand20g
protein/
day,encouragement
13weeks
Placeb
o(blinded)
(encouragement)
FEV1,12MWT,well-b
eing
10111(4)
Fuenzalida
etal.14
5/4
Maln
ourishedinpatientsand
outpatients
78.5%
IBW
62.4years
ONS(SustacalHC,1kcal/mL)
ONStarget:Upto1080kcal/dayandup
to46gprotein/day
3weeksinpatient+
3weeks
outpatie
nt(6weekstotal)
Usualdiet
FEV1,Lymphocytecount,
T-helper/suppressor
cells
10000(1)
Rogers
etal.15
15/12
Maln
ourished
78%
versus79%IBW
64ye
ars
Outp
atients(interventiongroup
admittedforfirst4weeks)
ONS(various,self-selected)tailoredto
individu
aldietaryhabitsanddietary
advice
ONStarget:Intakes>1.7
REEand
minimu
m1.5gprotein/kgperday
15weeks
Usualdiet
PImax,PEmax,HGS,
12MWT,
breathlessnessrat
ing,
QoL
10000(1)
Schols
etal.16
33/38
Nour
ished
102.4
%IBW
inpatient
PRprogramme(nothospital)
meanageunclear
ONS(MixtureofNutridrink,Protifar,
Fantomalt,Oil;sevenmixturesof
differen
tflavours;2.1kcal/mL)
ONStarget:+420kcal/dayand15g
protein/
day,encouragementtoeat
regular
meals
8weeks
Usualdiet(and
enco
uragementwith
oral
diet)
FEV1,PImax,12MW
T
10001(2)
Nutrition support in COPD 619
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
5/14
Table
2
Continued
Study
Samplesize
(treatment/
control)
C
haracteristics/setting
(interventionvs
control)
Nu
tritionalintervention
(type/prescribed
amount/duration)
Co
ntrolgroup
Outcomemeasur
es
Studyquality
(Jadadscore)
Schols
etal.22
39/25
Maln
ourished
84.1%
IBW
Inpatient
PRprogramme(nothospital)
Meanageunclear
ONS(MixtureofNutridrink,Protifar,
Fantomalt,Oil;sevenmixturesof
differen
tflavours;2.1kcal/mL)
ONStarget:+420kcal/dayand15g
protein/
day,encouragementtoeat
regular
meals
8weeks
Usualdietand
enco
uragementwith
meals
FEV1,PImax,12MW
T
10001(2)
Steiner
etal.24
42/43
Nour
ished/malnourished
~105%IBW
(23.9
vs23.5kg/m2)
Outp
atients
PRprogramme
66ve
rsus68years
ONS(Respifor,1.5kcal/mL)
ONStarget:+570kcal/dayand28g
protein/
day
7weeks
Placeb
o(blinded)
HGS,ISWT,ESWT,Q
oL
10111(4)
ETF
Whittaker
etal.21
6/4
Maln
ourished
76%
versus82%IBW
Inpatients
71ve
rsus64years
Nocturnal
ETF(Isocal)
ETFtarget;feeddelivered:atleast
1000kcal/dayor1.7
REEwhichever
greater
and34gprotein
(nasodu
odenal/jejunaltubefeeding)
16days
Placeb
o
ETF(equivalent
volumeproviding
2 kgwere associated with significantly improved survivalin keeping with a previous review reporting that sig-nificant functional improvements were seen in mal-nourished patients receiving ONS when weight gainwas >2 kg.7 It appears that this level of weight gainshould be a therapeutic target in malnourished COPD
PF Collinset al.624
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
10/14
patients, especially as recently reviewed evidencehighlights that this level of weight gain is achievablein malnourished COPD patients.17 The current reviewconfirms that weight gain of this magnitude is associ-ated with functional improvements in this patientgroup.
In the clinical setting, increasing importance isbeing placed on the assessment of functional out-
comes. HGS is not only a reliable marker of peripheralmuscle strength but it also predicts clinical out-comes69 such as mortality, morbidity, postoperativecomplications and increased length of hospital stay.Inthe elderly, a loss of grip strength often means a lossof independence. Although muscle strength is closelyrelated to mid-arm muscle area,70whole body proteincontent,71 and even body weight and BMI,72 a varietyof studies suggest that changes in muscle functioncan occur independently of muscle mass.7 It hasrecently been suggested that muscle strengthresponds faster to nutritional depletion and repletionthan anthropometric measures such as BMI andfat-free mass69 probably as a result of increased avail-
ability of energy, electrolytes and micronutrients inmuscle. Therefore, the improvement in musclestrength induced by nutritional intervention in mal-nourished COPD patients is likely to be due to a com-bination of increased force generated by the availablemuscle and increased muscle mass, which is consist-ent with the increase in mid-arm muscle circumfer-ence (or area) reported in RCT of COPD17 and otherconditions.73 Mid-arm muscle area has been found tobe a better predictor of mortality than BMI in patientswith COPD.74 Therefore, nutritional support leadingto weight gain (>2 kg) and increased mid-arm musclecircumference could confer survival benefits as sug-gested by previous studies.68,75
Exercise tests in COPD have also been found topredict outcomes,76 such as mortality and postopera-tive complications.77,78 This review examined theeffect of nutritional support in COPD patients under-taking different types of walking and shuttle tests per-formed on a flat surface, but the reviewed studieswere not amenable to meta-analysis. However, four ofthe five studies favoured the nutritional supportgroup, and the only studies reporting significantimprovements in performance also favoured thosereceiving nutritional support. While these tests havelimitations (e.g. some patients still have difficultieswalking faster on flat surfaces as their conditionimproves, but they can walk up a steeper slope), theyat least assess important aspects of the patientsability to function in ways that are relevant to every-day life.79
The evidence based on the effect of nutritionalsupport on immunological function is very limitednot least because none of the three studies14,21,48 thatassessed restricted aspects of immune functionreported the results separately for the interventionand control groups. In addition, the total absencefrom these studies of cytokine measurements andacute phase proteins as markers of the inflammatoryresponse highlights the need to examine immune/inflammatory-nutrition interactions. This is becausethe immune system not only helps prevent and aid
recovery from respiratory infections but also becauseit is linked to the processes involved in nutritionaldepletion and repletion of body tissues and theirresponsiveness to nutritional support.34 Whetherexercise has a pro- or anti-inflammatory role in COPDis unclear;80,81 however, a recent trial82 involving acombination of low-intensity exercise education ses-sions and an ONS with immunomodulatory proper-
ties (immunonutrition) in a cohort of malnourished(mean BMI 18.0 kg/m2) patients with moderate COPDproduced some very promising results that includedimprovements in weight, peripheral and respiratorymuscle strength, exercise capacity, QoL, and a reduc-tion in inflammation (measured by interleukin-6,interleukin-8, tumour necrosis factor-a, high sensi-tive C-reactive protein levels). Further work isrequired to examine whether these improvements aredue to the exercise intervention, the immunonutri-tion (or other components of the ONS) or a combina-tion of these. Further work is also needed to examinethe extent to which the changes in outcome could bereproduced by using a standard ONS.
An outcome that was found to be unresponsive tonutritional support in the current review was lungfunction (assessed by tests such as FEV1, forced vitalcapacity and blood gases), but this is likely to reflectthe irreversible nature of lung pathology in COPD. Itmay seem surprising that the lack of an effect of nutri-tional support on objective tests of lung function weresometimes associated with significant improvementsin subjective measures of breathlessness. However,because malnutrition has effects on the centralnervous system, including modulation of the sensitiv-ity of the respiratory centre to hypoxic stimulation,81
it is plausible that nutritional support influencesthe sensation of breathlessness through centrally
mediated mechanisms. Interestingly, cross-sectionalstudies of men with COPD have reported that breath-lessness is inversely related to BMI independently ofrespiratory function tests (diffusing capacity tocarbon monoxide, partial arterial oxygen concentra-tion, P0.1/PI max).83 Breathlessness influences QoL,which probably explains the striking concordancebetween them, both within and between groups ofthe reviewed RCT.
The extent to which changes in functional outcomemeasures reflect clinically relevant improvements inpatient well-being can be difficult to establish. Forexample, a small change in muscle strength (whichmay be as little as a few percent, as in some of thereviewed studies) may go totally unnoticed in strongwell-nourished subjects, but in malnourishedpatients who are close to the threshold of disability,84
they may be easily noticed and make the differencebetween being able to get up and not get up from abed or a chair, and between being independent anddependent on others. Nevertheless, attempts havebeen made to establish the minimum clinically rel-evant changes associated with some of these tests. Forexample, it has been conservatively estimated thatthe minimum clinically important difference in 6-minwalking distance is 5480 m85, which exceeds thatfound in the only two nutrition intervention studiesthat employed the 6-min walk test (an improvement
Nutrition support in COPD 625
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
11/14
in favour of ONS by a mean of 4713 and 37 m66).However, much larger changes have been found withthe 12-min walk test, for example, an improvement of143 m has been attributed to ONS in the study ofRogers et al..15 The minimum clinically importantimprovement in incremental shuttle walk test hasbeen estimated to be 47.5 m. The minimum benefitdistinguishable by patients relates to 78.7 m.86 Of the
studies considered in the present systematic review,the only one that used the incremental shuttle walktest to examine the effects of ONS during pulmonaryrehabilitation24 found improvements in walking dis-tance in favour of the nutrition intervention groupthat were less than the suggested thresholds.However, the patients were studied during pulmonaryrehabilitation and the effect of ONS in combinationwith the other treatments showed a statistically sig-nificant overall improvement of 60 m. Because bothnon-malnourished (87%) and malnourished patients(13%) received ONS if they were randomized to thenutritional support arm of the study, it is possible thatthose with malnutrition responded differently from
those without malnutrition, but such informationwas not reported. The benefits of exercise rehabilita-tion are well established;87 however, as alluded to bySteiner and colleagues,24 it can produce a negativeenergy balance that might require reversal by supple-mentation before an improvement in training out-comes can be demonstrated. A recent RCT of patientswith chronic respiratory failure, the majority of whomhad COPD, participating in an exercise rehabilitationprogramme and classified as malnourished (BMI21.5, SD 3.8 kg/m2 and fat-free mass deplete) foundthat nutritional support (ONS 3per day), educationand oral testosterone undecanoate led to significantimprovements in body weight, fat-free mass, strength
and function above control.
62
At present, it is unclearwhether all malnourished COPD patients undertak-ing exercise training should receive additional nutri-tional support or indeed whether training shouldcommence in those who are malnourished withoutnutritional support.61 It would appear pertinent torecommend that all COPD patients at risk of malnu-trition should receive some form of nutritionalsupport during rehabilitation and recommendationsare required.
The present analysis also examined the effect ofpotential explanatory variables, such as duration ofintervention with nutritional support, % IBW and ageof the participants, on functional outcomes (PI max,PE max and HGS), but generally, they were not foundto be significantly related to the outcomes. This is nottoo surprising given that the meta-regressionsinvolved a small numbers of studies that differed indesign and prescribed amounts of nutritional support(see Table 2), and also involved examination of eachvariable individually. In addition, there was only smallvariation between the mean age of the populationsinvolved with different studies (6269 years) and insome cases involved significant effects on outcomesfollowed short periods of supplementation (e.g. sig-nificant improvement in PE max reported in onestudy after 16 days of supplementation).21 Furtherinsights might emerge if individual patient data
(instead of mean study data) were analysed together,but unfortunately, such data are not available.
To understand the significance, strengths and limi-tations of this review and the way it differs from theupdated Cochrane review,88 it is necessary to considercertain methodological issues. Although the conclu-sions of both reviews appear to be similar (and both atvariance with those of the earlier Cochrane review,12
the two should not be confused because apartfrom not addressing the same issues, they have useddifferent methodology to meta-analyse differentstudies, which were selected according to differentcriteria.
The present review excluded three studies,61,63,82
which were also absent from the previous Cochranereview. However, in the updated Cochrane review,these three studies contributed to the assessment ofalmost all of the functional outcomes, dominatingsome of the analyses such as the overall health-related QoL (accounting for three out of the fourstudies) and their domains (two out of three studies ineach domain61,82) and the 6-min walk test(three out of
five studies). The studies totally dominated the meta-analyses of quadriceps strength (only two studies61,63),yet in the present review, data on quadriceps strengthfrom another paper were able to be used.24 Two of thethree papers were excluded from the present reviewbecause they both incorporated an exercise pro-gramme in the nutritional support arm of the studyand not in the control arm,61,63 and one of them63 alsoincluded additional interventions in the nutritionalsupport arm and not the control arm. (The depletedpatients who received nutritional support in thisstudy accounted for minority of the population,which was predominantly overweight with mildCOPD.) These study designs make it difficult to isolate
the effects of nutritional support. The multiplereported functional outcomes in favour of nutritionalsupport arm may have been due to the non-nutritional interventions or a combination of nutri-tional and non-nutritional interventions. The thirdstudy82 was not included in the present reviewbecause it became available after the literature searchwas carried out. It involved a nutritional supplementwith immunomodulatory properties, which can beattributed to an anti-inflammatory whey peptide,pharmacological doses of the anti-oxidant vitaminsC, E and A, and fish oils. Arguably, this study should betreated separately from other studies, none of whichinvolved an immunonutrition feed.
In the present review, the meta-analyses examinedwhether the changes induced by the interventionsdiffered between the two arms of studies, whereas inboth the previous and updated Cochrane reviews,most of the meta-analyses, including those involvingPI max and PE max, involved only the values at theend of the intervention period. It is considered pref-erable to generally use the change method than theend value method to assess the impact of interven-tions, especially when there is a relatively large base-line imbalance (which could fortuitously affect thetwo arms of individual studies in opposite directions(e.g. for variables such as PI max and PE max)).Another difference between the two reviews concerns
PF Collinset al.626
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
12/14
the uncertainty associated with imputation ofmissing data (missing SE or SD). In the present review,imputation involved only 1 of the 12 studies,13
affected only the control group (for PI max, PE maxand HGS), and was alwaysaccompanied by sensitivity(uncertainty) analysis, which assessed the potentialerrors associated with imputation. The uncertaintyassociated with the some of the analyses in the
updated Cochrane review appears is less clearbecause imputation involved 5 out of 14 studies (andmore than half of the studies in some meta-analyses,such as those involving changes in anthropometryincluding weight, and 6-min walk test), often botharms of some studies or the difference between themand in the absence of sensitivity analyses.
Although the type of functional outcomes exam-ined by the two reviews was similar, the presentreview systematically considered HGS and immuno-logical function, which was not the case with either ofthe Cochrane reviews.12,88 In addition, the presentreview provided new data using meta-regression(involving duration of intervention, % IBW, age and as
moderators) and considered the minimally importantclinical differences and related the findings associ-ated with one type of outcome variable to that ofanother another (e.g. the extent of weight gain asso-ciated with improvements in functional outcomes).In contrast, the Cochrane review, following the formalformat of Cochrane Collaboration to produce a docu-ment of almost 100 pages long, included moredetailed information about individual studies, listedthe excluded studies and undertook some subgroupmeta-analyses, such as those involving the compo-nents of QoL (made possible by inclusion of the threenew studies that did not feature in this review).However, the present review included a semiquanti-
tative and narrative description of QoL data and well-being13,15,24,52 that were not synopsized by theCochrane review.
Because a cure is impossible for COPD patients, amajor goal in the management of the disease is theimprovement or maintenance of body function andQoL. This systematic review describes the types andmagnitude of functional benefits that are likely toarise through nutritional support. It suggests that atleast some of the adverse functional consequences ofsevere COPD are reversible by nutritional support.The review also suggests that while several of thestudies were judged to be of high quality, many wereof lower quality, and therefore, the evidence base forthe role of nutritional support in COPD needs to bestrengthened with sufficiently powered RCT.
REFERENCES
1 Gosselink AT, Smit AJ, Crijns HJ et al. Alteration of peripheral
vasodilatory reserve capacity after cardioversion of atrial fibril-lation.Eur. Heart J.1996;17: 92634.
2 Bernard S, LeBlanc P, Whittom Fet al. Peripheral muscle weak-
ness in patients with chronic obstructive pulmonary disease.Am. J. Respir. Crit. Care Med.1998;158: 62934.
3 Seymour JM, Spruit MA, Hopkinson NSet al. The prevalence of
quadriceps weakness in COPD and the relationship with diseaseseverity.Eur. Respir. J.2010;36: 818.
4 Schols AM, Soeters PB, Dingemans AM et al. Prevalence and
characteristics of nutritional depletion in patients with stable
COPD eligible for pulmonary rehabilitation.Am. Rev. Respir. Dis.
1993;147: 11516.
5 Cano NJ, Roth H, Court-Ortune Iet al. Nutritional depletion in
patients on long-term oxygen therapy and/or home mechanical
ventilation. Eur. Respir. J.2002;20: 307.
6 Eisner MD,Iribarren C, Blanc PD et al. Development of disability
in chronic obstructive pulmonary disease: beyond lung func-
tion.Thorax2011;66: 10814.7 Stratton RJ, Green CJ, Elia M.Disease-Related Malnutrition: An
Evidence Based Approach to Treatment. CABI Publishing (CABI
International), Oxford, 2003.
8 Ezzell L, Jensen GL. Malnutrition in chronic obstructive pulmo-nary disease.Am. J. Clin. Nutr.2000;72: 14156.
9 Coxson HO, Chan IH, Mayo JR et al. Early emphysema in
patients with anorexia nervosa. Am. J. Respir. Crit. Care Med.
2004;170: 74852.
10 Ferreira I, Brooks D, Lacasse Yet al. Nutritional intervention in
COPD: a systematic overview.Chest2001;119: 35363.11 Ferreira I. Chronic obstructive pulmonary disease and malnutri-
tion: why are we not winning this battle? J. Pneumol. 2003; 29:
10715.
12 Ferreira IM, Brooks D, Lacasse Yet al. Nutritional supplementa-
tion for stable chronic obstructive pulmonary disease.Cochrane
Database Syst. Rev.2005; (2): CD000998.13 Efthimiou J, Fleming J, Gomes Cet al. The effect of supplemen-
tary oral nutrition in poorly nourished patients with chronic
obstructive pulmonary disease. Am. Rev. Respir. Dis. 1988; 137:
107582.
14 Fuenzalida CE, Petty TL, Jones ML et al. Theimmuneresponsetoshort-termnutritional interventionin advancedchronic obstruc-
tive pulmonary disease.Am. Rev. Respir. Dis. 1990;142: 4956.
15 Rogers RM, Donahoe M, Costantino J. Physiologic effects of oral
supplemental feeding in malnourished patients with chronic
obstructive pulmonarydisease. A randomized control study.Am.
Rev. Respir. Dis.1992;146: 15117.
16 Schols AM, Soeters PB, Mostert R et al. Physiologic effects of
nutritional support and anabolic steroids in patients with
chronic obstructive pulmonary disease. A placebo-controlled
randomized trial.Am. J. Respir. Crit. Care Med.1995;152(4 Pt 1):126874. [nourished patients].17 Collins PF, Stratton RJ, Elia M. Nutritional support in chronic
obstructive pulmonary disease: a systematic review and meta-
analysis.Am. J. Clin. Nutr.2012;95: 138595.
18 Higgins JPT, GreenS. CochraneHandbook for Systematic Reviews
of Interventions. Version 5.0.2. The Cochrane Collaboration,2009. [Accessed Jun 2012] Available from URL: www.cochrane-
handbook.org
19 Centre for Reviews and Dissemination. Systematic Reviews:
CRDs Guidance for Undertaking Reviews in Health Care. CRD,
University of York, York, UK, 2009.
20 Moher D, Cook DJ, Eastwood S et al. Improving the quality ofreports of meta-analyses of randomised controlled trials: the
QUOROM statement. Quality of reporting of meta-analyses.Lancet1999;354: 1896900.
21 Whittaker JS, Ryan CF, Buckley PAet al. The effects of refeedingon peripheral and respiratory muscle function in malnourishedchronic obstructive pulmonary disease patients.Am. Rev. Respir.
Dis.1990;142: 2838.
22 Schols AM, Soeters PB, Mostert R et al. Physiologic effects of
nutritional support and anabolic steroids in patients with
chronic obstructive pulmonary disease. A placebo-controlled
randomized trial.Am. J. Respir. Crit. Care Med.1995;152(4 Pt 1):126874. [malnourished patients].
23 Jadad AR, Moore RA, Carroll D et al. Assessing the quality of
reports of randomized clinical trials: is blinding necessary?Control. Clin. Trials1996;17: 112.
24 Steiner MC, Barton RL, Singh SJet al. Nutritional enhancementof exercise performance in chronic obstructive pulmonary
Nutrition support in COPD 627
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
13/14
disease: a randomised controlled trial. Thorax 2003; 58: 745
51.
25 Weekes CE, Emery PW, Elia M. Dietary counselling and foodfortification in stable COPD: a randomised trial. Thorax2009; 64:
32631.
26 Adams G. Effect of nasogastric feedings on arterial oxygen
tension in patients with symptomatic chronic obstructive pul-
monary disease.Heart Lung1988;17: 594.
27 Aguilaniu B, Goldstein-Shapses S, Pajon Aet al. Muscle protein
degradation in severely malnourished patients with chronicobstructive pulmonary disease subject to short-term total
parenteral nutrition.J. Parenter. Enteral. Nutr. 1992;16: 24854.
28 Akrabawi SS, Mobarhan S, Stoltz RRet al. Gastric emptying, pul-
monary function, gas exchange, and respiratory quotient afterfeeding a moderate versus high fat enteral formula meal in
chronic obstructive pulmonary disease patients.Nutrition1996;12: 2605.
29 Angelillo VA, Bedi S, Durfee Det al. Effects of low and high car-
bohydratefeedings in ambulatorypatients withchronicobstruc-
tive pulmonary disease and chronic hypercapnia. Ann. Intern.
Med.1985;103(6 Pt 1): 8835.
30 Borum ML, Lynn J, Zhong Z et al. The effect of nutritional sup-
plementation on survival in seriously ill hospitalized adults: an
evaluation of theSUPPORT data.Study to Understand Prognoses
and Preferences for Outcomes and Risks of Treatments. J. Am.
Geriatr. Soc.2000;48(5 Suppl): S338.31 Broekhuizen R, Creutzberg EC, Weling-Scheepers CAet al. Opti-
mizing oral nutritional drink supplementation in patients with
chronic obstructive pulmonary disease. Br. J. Nutr. 2005; 93: 965
71.
32 Broekhuizen R, Wouters EF, Creutzberg EC et al. Polyunsatu-rated fattyacids improveexercise capacityin chronic obstructive
pulmonary disease.Thorax2005;60: 37682.
33 Cai B, Zhu Y, Ma Yet al. Effect of supplementing a high-fat,
low-carbohydrate enteral formula in COPD patients. Nutrition
2003;19: 22932.34 Creutzberg EC, Schols AM, Weling-Scheepers CAet al. Charac-
terization of nonresponse to high caloric oral nutritional therapy
in depleted patients with chronic obstructive pulmonary
disease. Am. J. Respir. Crit. Care Med.2000;161(3 Pt 1): 74552.
35 Creutzberg EC, Wouters EF, Mostert R et al. Efficacy of nutri-tional supplementation therapy in depleted patients withchronic obstructive pulmonary disease. Nutrition 2003; 19:
1207.
36 Deacon SJ, Vincent EE, Greenhaff PLet al. Randomized control-
led trial of dietary creatine as an adjunct therapy to physical
training in chronic obstructive pulmonary disease.Am. J. Respir.
Crit. Care Med. 2008;178: 2339.
37 Dore MF, Laaban JP, Orvoen-Frija E et al. Role of the thermic
effect of food in malnutrition of patients with chronic obstruc-
tive pulmonary disease.Am. J. Respir. Crit. Care Med.1997;155:
153540.38 Efthimiou J, MounseyPJ, Benson DN et al. Effect of carbohydrate
rich versus fat rich loads on gas exchange and walking perform-
ance in patients with chronic obstructive lung disease. Thorax
1992;47: 4516.
39 Faager G, Soderlund K, Skold CM et al. Creatine supplementa-tion and physicaltraining in patients with COPD:a doubleblind,placebo-controlled study. Int. J. Chron. Obstruct. Pulmon. Dis.
2006;1: 44553.
40 Felbinger TW, Suchner U. Nutrition for the malnourished
patient with chronic obstructive pulmonary disease: more is
better!Nutrition2003;19: 4712.41 Ferreira IM, Verreschi IT, Nery LE et al. The influence of 6
months of oral anabolic steroids on body mass and respiratory
muscles in undernourished COPD patients. Chest 1998; 114:
1928.
42 Forli L, Pedersen JI, Bjortuft O et al. Dietary support to under-
weight patients with end-stage pulmonary disease assessed forlung transplantation.Respiration2001;68: 517.
43 Fuld JP, Kilduff LP, Neder JAet al. Creatine supplementation
during pulmonary rehabilitation in chronic obstructive pulmo-
nary disease.Thorax2005;60: 5317.
44 Goris AH, Vermeeren MA, Wouters EFet al. Energy balance indepleted ambulatory patients with chronic obstructive pulmo-
nary disease: the effect of physical activity and oral nutritional
supplementation. Br. J. Nutr. 2003;89: 72531.
45 Grigorakos L, Sotiriou E, Markou Net al. Combined nutritional
support in patients with chronic obstructive pulmonary disease
(COPD), under mechanical ventilation (MV). Hepatogastroenter-ology2009;56: 16124.
46 HoogendoornM, vanWetering CR,Schols AM et al. Is INTERdis-
ciplinary COMmunity-based COPD management (INTERCOM)
cost-effective? Eur. Respir. J. 2010;35: 7987.
47 Iovinelli G, Marinangeli F, Ciccone Aet al. Parenteral nutritioninventilated patients with chronic obstructive pulmonary disease:
long chain vs medium chain triglycerides. Minerva Anestesiol.
2007;73: 6576.
48 Knowles JB, Fairbarn MS, Wiggs BJ et al. Dietary supplementa-
tionand respiratory muscle performance in patientswith COPD.Chest1988;93: 97783.
49 KuboH, HondaN, Tsuji F et al. Effects of dietary supplementson
the Fischer ratio before and after pulmonary rehabilitation.Asia
Pac. J. Clin. Nutr.2006;15: 5515.
50 Lewis MI, Belman MJ, Dorr-Uyemura L. Nutritional supplemen-
tation in ambulatory patients with chronic obstructive pulmo-nary disease.Am. Rev. Respir. Dis.1987;135: 10628.
51 Marchesani F, Valerio G, Dardes N et al. Effect of intravenous
fructose 1,6-diphosphate administration in malnourished
chronic obstructive pulmonary disease patients with chronic
respiratory failure.Respiration2000;67: 17782.52 OtteKE, Ahlburg P, DAmore F et al. Nutritional repletion in mal-
nourished patients with emphysema. J. Parenter. Enteral. Nutr.
1989;13: 1526.
53 Planas M, Alvarez J, Garcia-Peris PAet al. Nutritional support
and quality of life in stable chronic obstructive pulmonarydisease (COPD) patients.Clin. Nutr.2005;24: 43341.
54 Saudny-Unterberger H, Martin JG, Gray-Donald K. Impact of
nutritional support on functional status during an acute exacer-
bation of chronic obstructive pulmonary disease. Am. J. Respir.
Crit. Care Med.1997;156(3 Pt 1): 7949.55 Slinde F, Gronberg AM, Engstrom CR et al. Individual dietaryintervention in patients with COPD during multidisciplinary
rehabilitation.Respir. Med.2002;96: 3306.
56 Vargas M, Puig A, de la Maza M et al. [Patients with chronic
airflow limitation: effects of the inspiratory muscle training with
threshold load valve, built with appropriate technology,associated to nutritional support]. Rev. Med. Chil. 1995; 123:
122534.
57 Vermeeren MA, Wouters EF, Geraerts-Keeris AJet al. Nutritional
support in patients with chronic obstructive pulmonary disease
during hospitalization for an acute exacerbation; a randomized
controlled feasibility trial.Clin. Nutr.2004;23: 118492.58 Vermeeren MA, Wouters EF, Nelissen LH et al. Acute effects of
different nutritional supplements on symptoms and functional
capacityin patientswith chronic obstructive pulmonarydisease.
Am. J. Clin. Nutr.2001;73: 295301.59 Wilson DO, Rogers RM, Sanders MHet al. Nutritional interven-
tion in malnourished patients with emphysema.Am. Rev. Respir.
Dis.1986;134: 6727.
60 Hoekstra J, Uil S, van den Berg J. Nutritional intervention versus
standardnutritional advice in malnourished COPD patients. Eur.
Respir. J.2005;26: 721s.
61 Sugawara K, Takahashi H, Kasai C et al. Effects of nutritionalsupplementation combined with low-intensity exercise in mal-
nourished patients with COPD.Respir. Med.2010;104: 18839.
62 Pison CM, Cano NJ, Cherion C et al. Multimodal nutritional
rehabilitation improves clinical outcomes of malnourished
patients with chronic respiratory failure: a randomised control-led trial.Thorax2011;66: 95360.
PF Collinset al.628
2013 The AuthorsRespirology 2013 Asian Pacific Society of Respirology
Respirology(2013) 18, 616629
-
8/11/2019 Nutritional Support and Functional Capacity in COPD
14/14
63 van Wetering CR, Hoogendoorn M, Broekhuizen Ret al. Efficacy
and costs of nutritional rehabilitation in muscle-wasted patients
with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTER-
COM trial.J. Am. Dir. Assoc.2010;11: 17987.
64 Baldi S, Aquilani R, Pinna GD et al. Fat-free mass change after
nutritional rehabilitation in weight losing COPD: role of insulin,
C-reactive protein and tissue hypoxia. Int. J. Chron. Obstruct.
Pulmon. Dis.2010;5: 2939.
65 Laviolette L, Lands LC, Dauletbaev N et al. Combined effect ofdietary supplementation with pressurized whey and exercise
training in chronic obstructive pulmonary disease: a rand-
omized, controlled, double-blind pilot study. J. Med. Food2010;13: 58998.
66 DeLetter M.A Nutritional Intervention for Persons with Chronic
Airflow Limitation. University of Kentucky, Lexington, KY, 1991.
67 The Global Initiative for Chronic Obstructive Lung Disease
(GOLD). Pocket guide to COPD diagnosis, management, and
prevention. 2011. [Accessed Jun 2012] Available from URL: www.
goldcopd.org68 Schols AM, Slangen J, Volovics Let al. Weight loss is a reversible
factor in the prognosis of chronic obstructive pulmonary
disease.Am. J. Respir. Crit. Care Med.1998;157(6 Pt 1): 17917.
69 Norman K, Stobaus N, Gonzalez MC et al. Hand grip strength:
outcome predictor and marker of nutritional status. Clin. Nutr.
2011;30: 13542.70 Hornby ST, Nunes QM, Hillman TEet al. Relationships between
structural and functional measures of nutritional status in a nor-
mally nourished population.Clin. Nutr.2005;24: 4216.
71 Peng S, Plank LD, McCall JL et al. Body composition, muscle
function, and energy expenditure in patients with liver cirrhosis:a comprehensive study.Am. J. Clin. Nutr.2007;85: 125766.
72 Budziareck MB, Pureza Duarte RR, Barbosa-Silva MC. Reference
values and determinants for handgrip strength in healthy sub-
jects.Clin. Nutr.2008;27: 35762.
73 Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supple-
ments. Ageing Res. Rev.2012;11: 27896.
74 Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MAet al.
Mid-arm muscleareais a betterpredictor of mortalitythan body
mass index in COPD.Chest2005;128: 210815.75 Prescott E, Almdal T, Mikkelsen KL et al. Prognostic value ofweight change in chronic obstructive pulmonary disease: results
from the Copenhagen City Heart Study. Eur. Respir. J. 2002; 20:
53944.
76 Oga T, Nishimura K, Tsukino M et al. Analysis of the factors
related to mortality in chronic obstructive pulmonary disease:
roleof exercise capacityand health status.Am. J. Respir. Crit. Care
Med.2003;167: 5449.77 Arozullah AM, Khuri SF, Henderson WGet al. Development and
validation of a multifactorial risk index for predicting postopera-
tive pneumonia after major noncardiac surgery. Ann. Intern.
Med.2001;135: 84757.
78 Datta D, Lahiri B. Preoperative evaluation of patients
undergoing lung resection surgery. Chest 2003; 123: 2096103.
79 Porszasz J, Emtner M, Goto S et al. Exercise training decreases
ventilatory requirements and exercise-induced hyperinflation at
submaximal intensities in patients with COPD.Chest2005;128:202534.
80 Koechlin C, Couillard A, Cristol JP et al. Does systemic inflam-
mation trigger local exercise-induced oxidative stress in COPD?Eur. Respir. J.2004;23: 53844.
81 Garrod R, Ansley P, Canavan Jet al. Exercise and the inflamma-
tory response in chronic obstructive pulmonary disease(COPD)does training confer anti-inflammatory properties in
COPD?Med. Hypotheses2007;68: 2918.
82 Sugawara K, Takahashi H, Kashiwagura T et al. Effect of anti-
inflammatory supplementation with whey peptide and exercise
therapy in patients with COPD. Respir. Med. 2012; 106: 1526
34.83 de Torres JP,Casanova C, Montejode Garcini Aet al. Genderand
respiratory factors associated with dyspnea in chronic obstruc-
tive pulmonary disease.Respir. Res.2007;8: 117.
84 World Health Organization. Active Aging: A Policy Framework.
WHO, Madrid, Spain, 2002.85 Wise RA, Brown CD. Minimal clinically important differences in
the six-minute walk test and the incremental shuttle walking
test.COPD2005;2: 1259.
86 Singh SJ, Jones PW, Evans Ret al. Minimum clinically important
improvement for the incremental shuttle walking test. Thorax
2008;63: 7757.
87 Lacasse Y, Goldstein R, Lasserson Tet al. Pulmonary rehabilita-
tion for chronic obstructive pulmonary disease.Cochrane Data-
base Syst. Rev.2006; (4): CD003793.
88 Ferreira IM,Brooks D, White J et al. Nutritional supplementationfor stable chronic obstructive pulmonary disease. Cochrane
Database Syst. Rev.2012; (12): CD000998.
Nutrition support in COPD 629
2013 The Authors Respirology (2013) 18 616629